Prenatal imaging identified situs inversus totalis, and whole exome sequencing found DNAH11 variants. The case highlights how ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...

Philip Awadalla has been studying population genetics for decades, and is still amazed at what scientists have learned from comparing genomes at scale. “There have been massive advancements in our ...

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

Convicted sex offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his own genetic material for ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

Genetic testing could provide critical health information, but it may not be right for everyone. NBC’s medical contributor Dr. Kavita Patel joins TODAY to break down who should do genetic testing, ...